Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Year-over-year book value per share growth
Latest
1.34%
↓ 95% vs avg
Percentile
P74
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
29.10%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 1.34% |
| Q3 2025 | -30.09% |
| Q2 2025 | 11.90% |
| Q1 2025 | -7.75% |
| Q4 2024 | -6.99% |
| Q3 2024 | -14.12% |
| Q2 2024 | -1.28% |
| Q1 2024 | -6.36% |
| Q4 2023 | -6.73% |
| Q3 2023 | -9.96% |
| Q2 2023 | 1.83% |
| Q1 2023 | -9.16% |
| Q4 2022 | -2.36% |
| Q3 2022 | -6.27% |
| Q2 2022 | -6.71% |
| Q1 2022 | -5.13% |
| Q4 2021 | -6.22% |
| Q3 2021 | -9.13% |
| Q2 2021 | -23.59% |
| Q1 2021 | 182.20% |
| Q4 2020 | -46.00% |
| Q3 2020 | 24.43% |
| Q2 2020 | 5.65% |
| Q1 2020 | -6.29% |
| Q4 2019 | -42.28% |
| Q3 2019 | 23.69% |
| Q2 2019 | -13.45% |
| Q1 2019 | -17.01% |
| Q4 2018 | -47.58% |
| Q3 2018 | 28.14% |
| Q2 2018 | -14.07% |
| Q1 2018 | -21.52% |
| Q4 2017 | -24.94% |
| Q3 2017 | 74.28% |
| Q2 2017 | -18.03% |
| Q1 2017 | -9.39% |
| Q4 2016 | -33.17% |
| Q3 2016 | 23.44% |
| Q2 2016 | -54.43% |
| Q1 2016 | 1286.93% |